Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Rx for Sjogren's syndrome symptoms nearing launch

Nov. 26, 1996

SKB to begin pivotal trials with antibody for RA

Nov. 22, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

Development of antiinflammatory/analgesic drug discontinued

Nov. 8, 1996

Progress on Scotia's rheumatoid arthritis treatment

Nov. 8, 1996

More convenient formulation of Lodine approved

Nov. 8, 1996

IL-1 receptor antagonists claimed by HMR/Affymax

Nov. 8, 1996

MMP inhibitors described by Procter & Gamble

Nov. 8, 1996

Sandoz reveals SLe(x)-mimetic compounds for treating inflammation

Nov. 8, 1996

Santen reports LTA4 hydrolase inhibitors

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...